TD Securities upgraded Extendicare (EXETF) to Buy from Hold with a C$32 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXETF:
- Extendicare’s ParaMed Closes $570 Million Acquisition of CBI Home Health
- Extendicare refreshes board as it deepens shift to health services
- Extendicare Declares March 2026 Dividend, Signals Confidence in Senior-Care Operations
- Extendicare price target raised to C$30 from C$25 at RBC Capital
- Extendicare Inc. Showcases Strong Growth in Earnings Call